Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Crossword Hires Advisory Board Chaired By Former Glaxo Security Head

Tue, 19th Mar 2019 13:15

LONDON (Alliance News) - Crossword Cybersecurity PLC on Tuesday said it has appointed a new advisory board that will be chaired by the former chief information security officer of GlaxoSmithKline PLC.

Crossword works with universities to find "promising cyber security intellectual property from research", which is then developed into commercial cyber security products and taken to market.

The new advisory board its intended to provide a range of perspectives on cyber security and to inform the company's strategy for product development.

Chairing the new advisory board is Robert Coles, previously chief information security officer at both GlaxoSmithKline and the NHS.

Also on the board will be Nick Houghton, former chief of the defence staff of the British Armed Forces, and former UK government Chief Scientific Officer for National Security Nick Jennings.

Una-May O'Reilly, principal research scientist at the computer science & artificial intelligence lab of the Massachusetts Institute of Technology, will also join the advisory board.

Crossword Chief Executive Tom Ilube said: "Crossword is exceptionally fortunate to be able to attract such a world class group of senior industry figures to our new advisory board. We have big plans for the future and being able to draw upon the guidance, advice and networks of our new advisors will be invaluable."

Shares in Crossword were up 3.8% at 379.00 pence on Tuesday.

Related Shares

More News
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac cause...

22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030 *

21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...

21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.